Morning Briefing
Summaries of health policy coverage from major news organizations
First Of Its Kind: Labcorp's At-Home Mpox PCR Test Gets Green Light
Labcorp, a lab services company based in North Carolina, today announced that the US Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for its PCR Test Home Collection Kit for mpox, the first at-home sample collection kit of its kind for the virus. In a statement, the company said the test is available for physicians to order for use in adults who have suspected mpox infections. (Schnirring, 4/10)
Mpox cases have been elevated since October, with an average of roughly 200 monthly cases detected per month, spurring efforts to avoid a summer surge like what was seen in 2022.聽Recent numbers from the Centers for Disease Control and Prevention (CDC) showed a startling difference between the first quarter of 2023 and 2024, with the first three months of this year seeing nearly聽double the rate of cases聽seen the same time last year.聽(Choi, 4/11)
On measles, bird flu, and botulism 鈥
A 4-year-old Detroit resident was diagnosed with measles, health officials announced Wednesday.聽The Detroit Health Department is alerting residents of the case and the exposure sites, including three healthcare facilities where the 4-year-old was taken for treatment.聽No other cases have been confirmed in relation to this incident at this time, including with the child's family members, who are following isolation protocols. (Powers, 4/10)
The North Carolina Department of Agriculture & Consumer Services (NCDAC) today announced that tests have confirmed highly pathogenic avian influenza (HPAI) in one of the state's dairy herds, raising the number of affected states to seven. Officials didn't detail the potential source of the virus, but said movements of cattle from earlier affected states has been suspended.聽(Schnirring, 4/10)
People in at least two states have been hospitalized with botulism-like illness after receiving cosmetic injections 鈥 commonly known as 鈥渂otox鈥 鈥 that were administered in non-medical settings. (McPhillips, 4/10)
On whooping cough, dengue, and sporotrichosis 鈥
Whooping cough is making a post-pandemic comeback in China, with cases surging more than 20-fold in the first two months of 2024. The world鈥檚 second-most populous country reported a combined 32,380 cases of pertussis 鈥 more commonly known as whooping cough 鈥 in January and February, compared with 1,421 cases during the same period in 2023, according to the National Disease Control and Prevention Administration. There were 13 deaths. (4/10)
Bug spray is out of stock across Argentina as the country confronts its worst-ever outbreak of dengue, a mosquito-borne illness that鈥檚 surged across Latin America amid high heat and heavy rains. Argentina reported 233,000 cases of dengue so far during the Southern Hemisphere鈥檚 summer 鈥 about eight times the number of case reported during the same week last year 鈥 and 161 deaths, according to its Health Ministry. (Tobias, 4/10)
A cluster of rare fungal infections was found in two pet cats and a vet who treated them, the Centers for Disease Control and Prevention said Wednesday in a report in the journal Emerging Infectious Diseases.聽The three cases 鈥 in late 2022 and early 2023 鈥 were caused by a fungus called Sporothrix schenckii.聽The CDC is monitoring the spread of a similar fungal infection, also in cats, in South America. That infection is spread by a related fungus, Sporothrix brasiliensis, which hasn鈥檛 been detected in the U.S. (Sullivan, 4/10)